The store will not work correctly when cookies are disabled.
US8618286, 4
ID: ALA3675232
PubChem CID: 44599934
Max Phase: Preclinical
Molecular Formula: C19H24N4OS
Molecular Weight: 356.49
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: N/C(=N\c1ccc2c(c1)OCCN2CCN1CCCC1)c1cccs1
Standard InChI: InChI=1S/C19H24N4OS/c20-19(18-4-3-13-25-18)21-15-5-6-16-17(14-15)24-12-11-23(16)10-9-22-7-1-2-8-22/h3-6,13-14H,1-2,7-12H2,(H2,20,21)
Standard InChI Key: NROWQKJIUNKMFX-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
1.5548 -3.6021 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5951 -3.0039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5973 -1.5031 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5981 1.5000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-2.6012 3.0008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9020 3.7494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9051 5.2502 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-5.1186 6.1100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6551 7.5366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1551 7.5366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6916 6.1100 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8971 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8971 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5981 -1.5000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8933 -3.7570 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.0312 -5.2378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4984 -5.5497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.2484 -4.2507 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2447 -3.1359 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 11 1 0
8 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 7 1 0
19 20 2 0
20 4 1 0
2 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 21 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 356.49 | Molecular Weight (Monoisotopic): 356.1671 | AlogP: 3.08 | #Rotatable Bonds: 5 |
Polar Surface Area: 54.09 | Molecular Species: BASE | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 9.09 | CX LogP: 3.06 | CX LogD: 0.41 |
Aromatic Rings: 2 | Heavy Atoms: 25 | QED Weighted: 0.66 | Np Likeness Score: -1.94 |
References
1. (2013) Benzoxazines, benzothiazines, and related compounds having NOS inhibitory activity, |